CHEK1 and melanoma: In the context of melanoma, a recent study showed that targeting replication stress, using a CHK1 inhibitor in combination with low doses of HU, led to increased DNA damage that can activate the cGAS-STING pathway, thus, inducing a pro-inflammatory cytokine and chemokine expression.